Page last updated: 2024-09-04

butylscopolammonium bromide and Granulocytic Leukemia, Chronic

butylscopolammonium bromide has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hino, M; Koh, KR; Nakamae, H; Nakane, T; Nakao, T; Terada, Y; Yamane, T; Yoshida, N	1

Other Studies

1 other study(ies) available for butylscopolammonium bromide and Granulocytic Leukemia, Chronic

Article	Year
[Chronic myelogenous leukemia complicated by drug-induced agranulocytosis]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2011, Volume: 52, Issue:5 Topics: Aged; Agranulocytosis; Benzamides; Butylscopolammonium Bromide; Colonoscopy; Female; Flumazenil; Granulocyte Colony-Stimulating Factor; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neutropenia; Piperazines; Premedication; Pyrimidines; Treatment Outcome	2011

Article

Year

[Chronic myelogenous leukemia complicated by drug-induced agranulocytosis].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2011, Volume: 52, Issue:5

Topics: Aged; Agranulocytosis; Benzamides; Butylscopolammonium Bromide; Colonoscopy; Female; Flumazenil; Granulocyte Colony-Stimulating Factor; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neutropenia; Piperazines; Premedication; Pyrimidines; Treatment Outcome

2011